American Lung Association
The TB Alliance's Stakeholders Association includes a range of institutions worldwide that share a clear interest, and a significant stake, in ensuring the development of a faster, better cure for tuberculosis. They include representatives from developing nations, government, NGOs, professional organizations, academia, foundations, and industry. Click here for info on our latest meeting
Many TB Alliance Stakeholders are original signatories of the Cape Town Declaration for TB Drug Development, which established the TB Alliance.
Stakeholders participate in the TB Alliance's outreach and advocacy efforts. They also advise and support the Board of Directors on various matters, including activities related to Adoption and Availability. These responsibilities are exercised through ongoing contact with the Alliance, the nomination of candidates for the Board of Directors, and the election of a Stakeholders Association President who sits on the Board.
Affiliates participate in the Stakeholders Association as non-voting members.
American Lung Association
American Thoracic Society
Association of the British Pharmaceutical Industry
Bill & Melinda Gates Foundation
Clinton Health Access Initiative
Community Representative, Mayowa Joel
Eli Lilly and Company
European Commission
GBC Health
Global Fund to Fight AIDS, TB and Malaria
Global Health Advocates
Indian Council of Medical Research
Infectious Diseases Society of America
International Union Against Tuberculosis and Lung Disease
Irish Aid
JATA Research Institute of Tuberculosis
KNCV Tuberculosis Foundation
National Centers for Disease Control and Prevention, China CDC
National Institute for Research in Tuberculosis, India
New Jersey Medical School Global Tuberculosis Institute
Novartis India, Ltd.
Oswaldo Cruz Foundation
Partners in Health
Population Services International
Rede Brasileira de Pesquisa em Tuberculose
RESULTS
RTI International
Sequella, Inc.
South African Medical Research Council
Stop TB Partnership